Related Experiment Video
Updated: May 21, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Are we diagnosing too many people with coeliac disease?
1Department of Gastroenterology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. imran.aziz@sth.nhs.uk
Insights
This review suggests that adults are not being diagnosed with coeliac disease too frequently. Case-finding with a low threshold for serological testing is recommended for optimal diagnosis of coeliac disease.
Area of Science:
- Gastroenterology
- Immunology
- Public Health
Background:
- Coeliac disease affects up to 1% of adults, with significant diagnostic delays (average 13 years) and undetected cases (estimated 8:1 ratio).
- Coeliac disease is associated with increased morbidity and mortality, and a gluten-free diet (GFD) improves quality of life and reduces complication risks.
Purpose of the Study:
- To evaluate whether current diagnosis rates for coeliac disease in adults are excessive.
- To review evidence supporting and opposing widespread screening versus case-finding for coeliac disease.
Main Methods:
- Systematic review of existing literature on coeliac disease diagnosis, screening, and outcomes.
- Analysis of diagnostic test accuracy, patient benefits from GFD, and cost-effectiveness of diagnosis.
Main Results:
- Diagnostic tests for coeliac disease lack 100% sensitivity and specificity.
- Screening studies in adults show poor uptake and adherence issues; individuals could often be identified through symptom questioning.
- Diagnosing coeliac disease can be cost-effective, offsetting costs through reduced medical expenditures, but this is population-prevalence dependent.
Conclusions:
- The evidence suggests that adults are not being over-diagnosed with coeliac disease.
- Optimal approach involves case-finding with a low threshold for serological testing, rather than broad screening.
Abstract:
This review will try to address the question of whether we are diagnosing too many people with coeliac disease. The key reasons for diagnosing coeliac disease may be that it is a common condition affecting up to 1% of the adult population. Delays in diagnosis are common. The average time delay reported by Coeliac UK (National Medical Patient Charity), for patients with symptoms prior to the diagnosis being made is 13 years. For every adult case detected, it is estimated that there are eight cases not detected. Patients with coeliac disease have an associated morbidity and mortality. In addition, quality of life studies suggest that the majority of patients benefit from a gluten-free diet (GFD). Furthermore, the GFD reduces or alleviates the risk of the associated complications. All of these facts could even be used to support the argument for screening! However, conversely the tests for coeliac disease are not 100% sensitive and specific. In addition, we do not know whether patients with milder symptoms will derive less benefit from treatment and are at less risk of complications. Furthermore, evidence presented in this review suggests that actual outcomes for screening studies in an adult population have revealed poor uptake and subsequently difficulties with adherence. What little published data that are available also infers that individuals recognised through screening programmes could have been detected if carefully questioned for symptoms. There is evidence to suggest that diagnosing celiac disease is cost-effective and that the diagnostic costs are offset by reduced medical expenditures, reduced hospital and general practice attendances, but this view depends on the population prevalence of coeliac disease. We believe on the basis of the evidence presented in this review that we are not diagnosing too many adults with coeliac disease. However, the authors consider case-finding with a low threshold for serological testing to be the optimal approach. If you look for coeliac disease you will find it.
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Other Disorders of Digestive System
Serum Laboratory Studies, Stool Test, Breath Test
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Inflammatory Bowel Disease III: Crohn's Disease